Cargando…
Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline
BACKGROUND: Pulmonary arterial hypertension (PAH) is a rare systemic disorder associated with considerable metabolic dysfunction. Although enormous metabolomic studies on PAH have been emerging, research remains lacking on metabolic reprogramming in experimental PAH models. We aim to evaluate the me...
Autores principales: | Zheng, Hai-Kuo, Zhao, Jun-Han, Yan, Yi, Lian, Tian-Yu, Ye, Jue, Wang, Xiao-Jian, Wang, Zhe, Jing, Zhi-Cheng, He, Yang-Yang, Yang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948901/ https://www.ncbi.nlm.nih.gov/pubmed/29751839 http://dx.doi.org/10.1186/s12931-018-0800-5 |
Ejemplares similares
-
Inhibitory effects of formononetin on the monocrotaline-induced pulmonary arterial hypertension in rats
por: Wu, Yonghui, et al.
Publicado: (2020) -
Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018) -
Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats
por: Jiang, Wei-Long, et al.
Publicado: (2019) -
Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022) -
The protective role of EP300 in monocrotaline-induced pulmonary hypertension
por: Yang, Lei, et al.
Publicado: (2023)